Skip to main content
Premium Trial:

Request an Annual Quote

Philip Smalley

Philip Smalley has joined Wamberg Genomic Advisors as its chief medical director. An internal medicine specialist, Smalley will be responsible for WGA's medical research. Prior to joining the firm, he served as senior vice president and global chief medical officer for RGA International. He also served as managing director of the Longer Life Foundation, an RGA/Washington University in St. Louis partnership that funds research on the determinants of longevity and promoting quality and quantity of life. Smalley received his medical degree from the University of Toronto, after which he practiced and taught medicine at a University of Toronto-affiliated teaching hospital. He is a fellow of the Royal College of Physicians and Surgeons of Canada and past president of the Canadian Life Insurance Medical Officers Association.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.